Low-dose ketamine infusion for the treatment of multiple sclerosis fatigue (INKLING-MS): Study protocol for a randomized, double-blind, active placebo-controlled phase II trial
Contemporary Clinical Trials（2023）
Abstract
This study can show whether intervening in the glutamatergic pathways would improves MS fatigue.
MoreTranslated text
Key words
Multiple sclerosis,Ketamine,Fatigue,Randomized controlled trial
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined